Several anti-tumoral effects of statins have been proposed to account for this beneficial effect: by inhibiting HMG-CoA reductase, statins alter the metabolism of cholesterol, a major component of cell membrane, and also decrease the synthesis of mevalonate, a precursor of products regulating the cell cycle [25], resulting in inhibition of tumor cell growth. This evidence concerns the gene HMGCR and neoplasm.